Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

    loading  Checking for direct PDF access through Ovid

Abstract

Insights into antitumor T-cell responses may help the development of more efficient treatments for lung cancer. The interplay between preexisting antitumor CD4+ T-cell responses and platinum-based chemotherapy is crucial to improve patient survival. Accumulating evidence confirms that selecting cancer patients in whom chemotherapy can activate an anticancer immune response would largely improve the success of novel therapeutic approaches.

Related Topics

    loading  Loading Related Articles